Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOCETAXEL\DOCETAXEL ANHYDROUS: 3,830 Adverse Event Reports & Safety Profile

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More
3,830
Total FAERS Reports
499 (13.0%)
Deaths Reported
1,438
Hospitalizations
3,830
As Primary/Secondary Suspect
273
Life-Threatening
90
Disabilities

First Report: 20010601 · Latest Report: 20240918

What Are the Most Common DOCETAXEL\DOCETAXEL ANHYDROUS Side Effects?

#1 Most Reported
Diarrhoea
409 reports (10.7%)
#2 Most Reported
Myelosuppression
404 reports (10.5%)
#3 Most Reported
Disease progression
289 reports (7.5%)

All DOCETAXEL\DOCETAXEL ANHYDROUS Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Diarrhoea 409 10.7% 129 195
Myelosuppression 404 10.6% 10 246
Disease progression 289 7.6% 65 46
Off label use 281 7.3% 51 115
Nausea 279 7.3% 92 104
Neutropenia 250 6.5% 46 85
Fatigue 236 6.2% 107 73
Pyrexia 221 5.8% 75 109
Vomiting 216 5.6% 79 93
Asthenia 190 5.0% 71 59
Anaemia 188 4.9% 29 79
Drug ineffective 184 4.8% 39 42
Decreased appetite 172 4.5% 74 53
Dyspnoea 162 4.2% 82 39
Febrile neutropenia 155 4.1% 40 91
Alopecia 148 3.9% 37 30
White blood cell count decreased 146 3.8% 7 58
Neuropathy peripheral 135 3.5% 27 38
Product use in unapproved indication 134 3.5% 8 88
Malignant neoplasm progression 126 3.3% 39 16

Who Reports DOCETAXEL\DOCETAXEL ANHYDROUS Side Effects? Age & Gender Data

Gender: 62.1% female, 37.9% male. Average age: 58.5 years. Most reports from: CN. View detailed demographics →

Is DOCETAXEL\DOCETAXEL ANHYDROUS Getting Safer? Reports by Year

YearReportsDeathsHosp.
2001 2 0 0
2007 1 0 0
2008 4 0 4
2009 5 0 0
2010 1 0 1
2011 15 2 2
2012 20 4 6
2013 16 0 7
2014 28 4 6
2015 45 19 20
2016 43 9 16
2017 48 10 25
2018 73 4 25
2019 66 6 28
2020 112 13 33
2021 136 17 45
2022 137 28 70
2023 582 67 301
2024 829 26 454

View full timeline →

What Is DOCETAXEL\DOCETAXEL ANHYDROUS Used For?

IndicationReports
Breast cancer 791
Product used for unknown indication 388
Her2 positive breast cancer 216
Breast cancer metastatic 200
Prostate cancer 182
Breast cancer female 159
Invasive ductal breast carcinoma 149
Prostate cancer metastatic 116
Lung adenocarcinoma 114
Chemotherapy 107

DOCETAXEL\DOCETAXEL ANHYDROUS vs Alternatives: Which Is Safer?

DOCETAXEL\DOCETAXEL ANHYDROUS vs DOCONEXENT DOCETAXEL\DOCETAXEL ANHYDROUS vs DOCONEXENT\ICOSAPENT DOCETAXEL\DOCETAXEL ANHYDROUS vs DOCONEXENT\ICOSAPENT\PHOSPHATIDYL SERINE DOCETAXEL\DOCETAXEL ANHYDROUS vs DOCOSANOL DOCETAXEL\DOCETAXEL ANHYDROUS vs DOCUSATE DOCETAXEL\DOCETAXEL ANHYDROUS vs DOCUSATE\SENNOSIDES DOCETAXEL\DOCETAXEL ANHYDROUS vs DOCUSATE\SENNOSIDES A AND B DOCETAXEL\DOCETAXEL ANHYDROUS vs DOFETILIDE DOCETAXEL\DOCETAXEL ANHYDROUS vs DOLUTEGRAVIR DOCETAXEL\DOCETAXEL ANHYDROUS vs DOLUTEGRAVIR\LAMIVUDINE

Official FDA Label for DOCETAXEL\DOCETAXEL ANHYDROUS

Official prescribing information from the FDA-approved drug label.